Chris Kalafatis
Overview
Explore the profile of Chris Kalafatis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
215
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Macfarlane S, Grimmer T, Teo K, OBrien T, Woodward M, Grunfeld J, et al.
J Prev Alzheimers Dis
. 2025 Jan;
12(1):100016.
PMID: 39800452
Background: There are no approved oral disease-modifying treatments for Alzheimer's disease (AD). Objectives: The objective of this study was to assess efficacy and safety of blarcamesine (ANAVEX®2-73), an orally available...
2.
Venkataraman A, Kandangwa P, Lemmen R, Savla R, Beigi M, Hammond D, et al.
BJPsych Open
. 2024 Dec;
11(1):e8.
PMID: 39696774
Background: The novel South London and Maudsley Brain Health Clinic (SLaM BHC) leverages advances in remote consultations and biomarkers to provide a timely, cost-efficient and accurate diagnosis in mild cognitive...
3.
Marefat H, Vahabi Z, Afzalian N, Khanbagi M, Karimi H, Ebrahiminia F, et al.
J Alzheimers Dis Rep
. 2023 Nov;
7(1):1133-1152.
PMID: 38025804
Background: In early Alzheimer's disease (AD), high-level visual functions and processing speed are impacted. Few functional magnetic resonance imaging (fMRI) studies have investigated high-level visual deficits in AD, yet none...
4.
Shore J, Kalafatis C, Stainthorpe A, Modarres M, Khaligh-Razavi S
Front Public Health
. 2023 Oct;
11:1240901.
PMID: 37841740
Objectives: The aim of this study was to develop a comprehensive economic evaluation of the integrated cognitive assessment (ICA) tool compared with standard cognitive tests when used for dementia screening...
5.
Modarres M, Kalafatis C, Apostolou P, Tabet N, Khaligh-Razavi S
Front Aging Neurosci
. 2023 Oct;
15:1243316.
PMID: 37781102
Background: Current primary care cognitive assessment tools are either crude or time-consuming instruments that can only detect cognitive impairment when it is well established. This leads to unnecessary or late...
6.
Guu T, Muurling M, Khan Z, Kalafatis C, Aarsland D, Ffytche D, et al.
Lancet Digit Health
. 2023 May;
5(6):e336-e337.
PMID: 37236695
No abstract available.
7.
Liu K, Kulatilake A, Kalafatis C, Smith G, King J, Serra-Mestres J, et al.
BJPsych Open
. 2022 Mar;
8(2):e63.
PMID: 35256037
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) has high morbidity and mortality in older adults and people with dementia. Infection control and prevention measures potentially reduce transmission...
8.
Karimi H, Marefat H, Khanbagi M, Kalafatis C, Modarres M, Vahabi Z, et al.
PLoS One
. 2022 Feb;
17(2):e0264058.
PMID: 35196356
Electroencephalography (EEG) has been commonly used to measure brain alterations in Alzheimer's Disease (AD). However, reported changes are limited to those obtained from using univariate measures, including activation level and...
9.
Kalafatis C, Modarres M, Apostolou P, Tabet N, Khaligh-Razavi S
JMIR Res Protoc
. 2021 Dec;
11(1):e34475.
PMID: 34932495
Background: Existing primary care cognitive assessment tools are crude or time-consuming screening instruments which can only detect cognitive impairment when it is well established. Due to the COVID-19 pandemic, memory...
10.
Rao R, Creese B, Aarsland D, Kalafatis C, Khan Z, Corbett A, et al.
Aging Ment Health
. 2021 Nov;
26(12):2432-2439.
PMID: 34766529
Objectives: Alcohol misuse is known to be a risk factor for dementia. This study aimed to explore the association between risky drinking and cognitive impairment in a cohort study of...